baber/WOPTO huggingface dataset:
Patent AU-2003240669-B2 (AU)
Title: Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
Inventor: FELDMAN DAVID LOUIS
IPC: A61K31/455
Filed: 2003-05-16
Granted: 2007-03-08
Abstract: The invention relates to a pharmaceutical composition comprising (i) a renin inhibitor, (ii) a calcium channel blocker (CCB), and (iii) a diuretic and to a method of treatment of a condition or a disease selected from the group consisting of hypertension, heart failure such as (acute and chronic) congestive heart failure, left ventricular dysfunction and hypertrophic cardiomyopathy, diabetic cardiac myopathy, supraventricular and ventricular arrhythmias, atrial fibrillation, atrial flutter, detrimental vascular remodeling, myocardial infarction and its sequelae, atherosclerosis, angina (whether unstable or stable), renal insufficiency (diabetic and non- diabetic), heart failure, angina pectoris, diabetes, secondary aldosteronism, primary and secondary pulmonary hypertension, renal failure conditions, such as diabetic nephropathy, glomerulonephritis (including IgA nephropathy), renal fibrosis, scleroderma, glomerular sclerosis, proteinuria of renal disease, and also renal vascular hypertension, diabetic retinopathy, the management of other vascular disorders, such as migraine, peripheral vascular disease, Raynaud's disease, luminal hyperplasia, cognitive dysfunction (such as Alzheimer's), glaucoma and stroke, pulmonary and hepatic fibrosis, fibrotic diseases resulting from accumulation of excess extracellular matrix induced by TGF, and proliferative diseases of smooth muscle cells, including uterine fibroids comprising administering a therapeutically effective amount of said pharmaceutical composition to a mammal in need of such treatment.
Patent AU-2004224784-B2 (AU)
Title: Racket
Inventor: TURZER HARALD
IPC: A63B49/08
Filed: 2004-03-24
Granted: 2011-04-07
Abstract: The invention concerns a racket for ball and shuttlecock games such as tennis, squash or badminton. With the objective of generally improving the playing characteristics of the racket and to adapt the racket to the ergonomic movements of the layer on serving, receiving and returning the ball with more effective utilization of the striking force, the racket has an S shaped configuration throughout and has a midline 5 running in a common S shape for the striking part 1, the shaft 2 and the grip 3, such that the upper and lower points of intersection of the head frame 6 and the striking part 1 lie on the midline 5, while the arrangement of shaft 2 and grip 3 follows the course of the midline 5 in their longitudinal extension and the cross sections of the profiles 6.1; 6.2 of the headframe 6 and shaft 2 are different in the halves of the racket separated by the midline 5-FIG. 1. The racket according to the invention has an arc-shaped grip 3 designed as a segment of a circle, designed and arranged with respect to the striking part 1 so that each of the tangents 10, 17 of the inner and outer arcs 16, 15 of the grip intersect the striking surface 9 of the striking part and the parts of the striking surface to the right side of the symmetry axis 14 of the striking part are limited on one side by an outermost tangent 10 running from the grip base 3.1 to the outer arc 15-FIG. 1.
Patent AU-2005211458-B2 (AU)
Title: L-(-)-moprolol L-(+)-tartrate
Inventor: MAUGERI CATERINA
IPC: C07C59/255
Filed: 2005-01-14
Granted: 2010-06-24
Abstract: L-(-)-moprolol L-(+)-tartrate salt (2:1), method for preparing it and pharmaceutical composition comprising it.
Patent AU-2005217093-B2 (AU)
Title: Generation of recombinant genes in prokaryotic cells by using two extrachromosomal elements
Inventor: GALIC TATJANA
IPC: C12N15/65
Filed: 2005-02-26
Granted: 2009-01-08
Abstract: The present invention relates in general to methods for generating and detecting recombinant DNA sequences in prokaryotic cells, in particular bacteria, by using two different extrachromosomal elements, in particular Saccharomyces cerevisiae and plasmids that can be used for conducting the inventive methods. DNA sequences for which these methods are relevant include protein-encoding and non-coding sequences.
Patent AU-2006210707-B2 (AU)
Title: Screening method
Inventor: ANNE DANIEL YVONNE
IPC: G01N33/72
Filed: 2006-02-01
Granted: 2011-10-13
Abstract: The present invention relates to a method for screening for variant peptides using mass spectrometry (MS). The present invention also relates to a system and a kit for performing the method.
Patent AU-2006213727-B2 (AU)
Title: 2-methylene-19-nor- (20S-24S) - 1alpha, 25-dihydroxyvitamin-D2
Inventor: PLUM LORI A
IPC: C07C401/00
Filed: 2006-02-10
Granted: 2011-08-18
Abstract: Compounds of formula I are provided where X, X, and X are independently selected from H or hydroxy protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological conditions.
Patent AU-2006261995-B2 (AU)
Title: Automotive articles prepared from filled TPO compositions, and methods of making the same
Inventor: SRIMANNARAYANA KAKARALA
IPC: C08K3/34
Filed: 2006-06-23
Granted: 2011-12-08
Abstract: An automotive part containing at least one component formed from a composition comprising the following: (i) a crystalline, isotactic propylene homopolymer, (ii) an ethylene/α-olefm elastomeric impact modifier, and (iii) a reinforcing grade of filler, for example, talc. The crystalline isotactic propylene homopolymer has a flex modulus of greater than about 1930 MPa and a heat deflection temperature (HDT) of greater than about 100°C; the ethylene/α-olefin interpolymer has a Tg of less than about -30°C, and a tan delta measured at 0.1 radians/s at 190°C of less than about 2; and the filler has a HDT reinforcing efficiency of at least about 2. The automotive part has an HDT of greater than about 100°C and a flex modulus of greater than about 1930 MPa.
Patent AU-2006265391-B2 (AU)
Title: Crucible for the crystallization of silicon
Inventor: GILBERT RANCOULLE
IPC: C30B15/10
Filed: 2006-06-30
Granted: 2011-09-01
Abstract: The invention relates to a crucible for the crystallization of silicon and to the preparation and application of release coatings for crucibles used in the handling of molten materials that are solidified in the crucible and then removed as ingots, and more particularly to release coatings for crucibles used in the solidification of polycrystalline silicon. The objective of the inventor was to provide a crucible which does not require the preparation of a very thick coating at the end user facilities, which is faster and cheaper to produce and which presents an improved release effect and which allows the production of silicon ingot without cracks. It has now been found that these problems can be solved with a crucible for the crystallization of silicon comprising a) A base body comprising a bottom surface and side walls defining an inner volume; b) A substrate layer comprising 80 to 100 wt. % of silicon nitride at the surface of the side walls facing the inner volume c) an intermediate layer comprising 50 to 100 wt. % of silica on the top of the substrate layer; and d) A surface layer comprising 50 to 100 wt. % of silicon nitride, up to 50 wt. % of silicon dioxide and up to 20 wt % of silicon on the top of the intermediate layer.
Patent AU-2006314037-B2 (AU)
Title: Targeted fusion proteins for cancer therapy
Inventor: NACHIAPPAN DHATCHANA MOORTHY
IPC: A61K38/17
Filed: 2006-11-16
Granted: 2010-09-23
Abstract: The invention relates to fusion proteins useful as therapeutics against cancer. The fusion protein comprises of cell-targeting moiety and apoptosis-inducing moiety. Cell-targeting moiety and apoptosis-inducing moiety are linked by a flexible linker, which are specifically recognized by cancer specific protease and cleaved in situ to release the apoptotic domain. In particular, the invention is illustrated by a recombinant fusion protein between human Vasoactive Intestinal Peptide (VIP) and BH3 domain of Bcl2 family protein, linked by a linker that has site for cancer specific proteases. The fusion protein specifically targets VIP receptor over-expressing cancer cells and induces cell-specific apoptosis after cleavage at the linker site by cancer specific proteases. Such fusion proteins are useful for the delivery of therapeutic/apoptotic moiety (peptides) to specific cells with perturbed expression of, but not limited to neuropeptide receptors.
Patent AU-2006331391-B2 (AU)
Title: Amorphous caesium aluminium fluoride complex, its production and use
Inventor: LEHMANN KLAUS-PETER
IPC: B23K35/36
Filed: 2006-12-20
Granted: 2012-04-19
Abstract: The subject matter of the present invention is an amorphous caesium aluminium fluoride complex, a method of producing it and the use of the complex as a flux, in particular for the soft soldering of aluminium.
Patent AU-2006331673-B2 (AU)
Title: Bicyclic heteroaryl compounds
Inventor: ROMERO JAN ANTIONETTE C
IPC: A61K31/4745
Filed: 2006-12-22
Granted: 2013-02-28
Abstract: This invention relates to compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.
Patent AU-2006351517-B2 (AU)
Title: The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof
Inventor: JIANHUI GUO
IPC: C07D233/68
Filed: 2006-12-06
Granted: 2011-12-22
Abstract: The present application discloses the pharmaceutically acceptable salts of imidazol-5-carboxylic acid derivatives, preparation methods and medicament compositions thereof. The present salts have good solubility in conventional solvents, such as methanol or water, and have good bioavailability in vivo. These salts can be used as therapeutical agents against hypertension.
Patent AU-2007216839-B2 (AU)
Title: A vehicle body and a vehicle
Inventor: MACLEAN COLIN ROBERT
IPC: B60P3/355
Filed: 2007-09-19
Granted: 2012-07-26
Abstract: A recreational vehicle that is a motor home is disclosed. The motor home includes a vehicle body shell arrangement 3 having a front wall 5 and a rear wall 7 and left 5 and right sides 9, 11 that together define an interior space. The interior space is divided up into a front seat region 13 and a rear living region 15. The rear living region 15 comprises rooms and arrangements that enable users to live in the motor home. The motor home includes a slide out 25 on the body shell 3 that is movable between a contracted position in which it is received within the body shell 10 arrangement 3 and an expanded position in which it projects out beyond the walls of the body shell arrangement 3. The slide out 25 has at least one bathroom fitting mounted thereon and forms at least part of a bathroom. The size of the bathroom is expanded significantly when the slide out is moved to its extended position and this considerably increases the amenity afforded by the bathroom 51. FIG. 4 FOR PUBLICATION FTO-o -LID
Patent AU-2007241433-B2 (AU)
Title: Process and device for printing containers
Inventor: VOLKER TILL
IPC: B67B3/00
Filed: 2007-04-03
Granted: 2011-10-27
Abstract: The invention relates to a process for the application of at least one imprint (VA) on a container surface, for example, the seal of a container (4), using at least one printing station (15) with at least one electrically-controlled printing unit (21).
Patent AU-2007248560-B2 (AU)
Title: Fermentive production of four carbon alcohols
Inventor: DONALDSON GAIL K
IPC: C12N15/52
Filed: 2007-05-02
Granted: 2013-02-14
Abstract: Methods for the fermentive production of four carbon alcohols are provided. Specifically, butanol, preferably 2-butanol is produced by the fermentive growth of a recombinant bacteria expressing a 2- butanol biosynthetic pathway. The recombinant microorganisms and methods of the invention can also be adapted to produce 2-butanone, an intermediate in the 2-butanol biosynthetic pathways disclosed herein.
Patent AU-2007250586-B2 (AU)
Title: Vane machine
Inventor: GRIGORIEV BORIS YURIEVICH
IPC: F04C2/344
Filed: 2007-05-16
Granted: 2012-06-28
Abstract: This invention relates to mechanical engineering and can be used in hydraulic machines, pumps, compressors and internal combustion engines. The purpose of this invention is to create a new vane machine featured by a simple design, durability and highly efficient pumping of the working medium. A vane machine according to the invention comprises a housing (1) with a inlet port (2) and an outlet port (3), and a rotor mounted in a cavity (4) of the housing (1) and constituted by a faceplate (5). The vane machine further comprises a guide cylinder (7) mounted eccentrically on the end surface of the housing (1) opposite to the faceplate (5), the guide cylinder (7) being rotatable and provided with a diametrical face grooves (8) and working vanes (6) mounted on the faceplate (5) and adapted for free rotation and movement in the grooves (8) as the faceplate (5) rotates. The eccentricity of the rotation axis of the working vanes (6) is equal to the eccentricity of the rotation axis of the guide cylinder (7). The profile of the cavity (4) of the housing (1) is oval, cylindrical, epicycloidal or curved, and the diameter of the guide cylinder 7 is D > 4å - L, while the length of the working vane (6) is L <= 4å x sin90/N.
Patent AU-2007261806-B2 (AU)
Title: Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV in insect cells
Inventor: BIESMANS DENNIS JOHAN
IPC: C12N15/864
Filed: 2007-06-20
Granted: 2013-08-15
Abstract: The present invention relates nucleic acid constructs for the production of recombinant parvoviral (e.g. adeno-associated viral) vectors in insect cells, to insect cells comprising such constructs and to methods wherein the cells are used to produce recombinant parvoviral virions. The insect cells preferably comprise a first nucleotide sequence encoding the parvoviral rep proteins whereby the initiation codon for translation of the parvoviral Rep78 protein is a suboptimal initiation codon that effects partial exon skipping upon expression in insect cells. The insect cell further comprises a second nucleotide sequence comprising at least one parvoviral (AAV) inverted 10 terminal repeat (ITR) nucleotide sequence and a third nucleotide sequence comprising a sequences coding for the parvoviral capsid proteins.
Patent AU-2007268402-B2 (AU)
Title: Method and apparatus for supplying fuel of LPG car having LPI system
Inventor: AN JEONG-HOON
IPC: F02M21/02
Filed: 2007-05-31
Granted: 2012-11-01
Abstract: Disclosed is method and apparatus for supplying fuel of LPG car having LPI system. More particularly, the present invention generates a gas fuel injection signal based on a gasoline fuel injection signal and directly injects LPG fuel within a fuel tank to a combustion chamber using the generated gas fuel injection signal to drive an engine. Therefore, an engine can be easily changed, the manufacturing cost of a duel car of LPG and gasoline can be reduced, and the manufacturing process thereof can be simplified.
Patent AU-2007290862-B2 (AU)
Title: Improved flow for port guided globe valve
Inventor: MCCARTY MICHAEL WILDIE
IPC: F16K47/04
Filed: 2007-06-22
Granted: 2013-07-25
Abstract: A valve assembly includes a valve body, a valve seat, and a valve plug (10). The valve body defines a flow path for a fluid. The valve plug is adapted for displacement between a closed position and an open position in the valve body. The valve plug includes a crown(26), a skirt (28)and a protrusion (30). The crown is for sealingly engaging the valve seat when the valve plug is in the closed position. The skirt defines a flow path for accommodating the fluid when the valve plug is in the open position. The protrusion is substantially concentrically aligned with the skirt. Each of the skirt or the protrusion have a surface treatment for enhancing the flow of the fluid through the valve when in the one or more open positions.
Patent AU-2007291886-B2 (AU)
Title: Method of treatment of photodermatoses
Inventor: WOLGEN PHILIPPE
IPC: A61K38/04
Filed: 2007-08-31
Granted: 2013-01-10
Abstract: A method for prophylactic or therapeutic treatment of photodermatoses that are caused or exacerbated by or associated with UVR exposure in a subject, particularly a human subject, which comprises the step of administering to said subject an amount of an alpha-MSH analogue effective to reduce the photosensitivity of the skin of the subject.
Patent AU-2007292295-B2 (AU)
Title: Fusion peptide therapeutic compositions
Inventor: CHILKOTI ASHUTOSH
IPC: C07K14/00
Filed: 2007-09-06
Granted: 2013-06-06
Abstract: Therapeutic compositions containing fusion proteins (FPs) including elastin-like peptides (ELPs) and peptide active therapeutic agents, and methods of making and using such compositions and fusion proteins. Therapeutic compositions of such type enable improved efficacy of the peptide active therapeutic agent to be achieved, in relation to the peptide active therapeutic agent alone. Enhanced efficacy of the peptide active therapeutic agent in the therapeutic composition may include improved solubility, bioavailability, bio-unavailability, half-life, etc., as compared to corresponding compositions containing the same peptide active therapeutic agent without associated ELPs.
Patent AU-2007297823-B2 (AU)
Title: New small molecule inhibitors of MDM2 and the uses thereof
Inventor: WANG SHAOMENG
IPC: A61K31/5377
Filed: 2007-08-30
Granted: 2012-04-19
Abstract: The invention relates to small molecules which function as inhibitors of the interaction between p53 and MDM2. The invention also relates to the use of these compounds for inhibiting cell growth, inducing cell death, inducing cell cycle arrest and/or sensitizing cells to additional agent(s).
Patent AU-2007299843-B2 (AU)
Title: Optimized antibodies that target HM1.24
Inventor: MUCHHAL UMESH S
IPC: C07K16/28
Filed: 2007-09-18
Granted: 2012-03-08
Abstract: The present disclosure describes antibodies that target HM1.24. In various aspects, the antibodies have specific CDR, variable, or full length sequences, have modifications with the parent antibody, or include at least one one modification relative to a parent antibodythat alters affinity to an FcγR or alters effector function as compared to the parent antibody. Nucleic acids encoding the antibodies and methods of using the antibodies are also disclosed.
Patent AU-2007303132-B2 (AU)
Title: Interventional catheters
Inventor: WALSH KATE
IPC: A61B17/32
Filed: 2007-10-03
Granted: 2013-03-28
Abstract: An interventional catheter incorporates an advanceable, rotatable operating head having a fixed blade cutter assembly and an adjustable blade cutter assembly. Aspiration ports and/or infusion ports providing access to a sealed lumen and aspiration and infusion systems are provided on, or in proximity to, the operating head. A shearing device may be provided within an aspiration port to further reduce the size of unwanted material during removal from a body lumen. A drive shaft provides rotation and torque from a drive system to the cutter assemblies and shearing device, and may be coupled to the cutter assembly by means of an articulating bearing assembly.
Patent AU-2007316426-B2 (AU)
Title: Vascular access devices including a tear-resistant septum
Inventor: RASMUSSEN WAYNE K
IPC: A61M31/00
Filed: 2007-11-06
Granted: 2013-03-07
Abstract: A vascular access device may include a body and a septum at least partially disposed in the body. The septum may include a slit and may be configured to resist tearing near the slit. A method of manufacturing a vascular access device may include providing a body and a septum within the body. The septum may include a slit and may be adapted and/or configured to resist tearing.
Patent AU-2007317913-B2 (AU)
Title: Methods of generating phosphorus fertilizers through the utilization of microbial fermentation technology
Inventor: GRECH NIGEL
IPC: C05F11/08
Filed: 2007-11-02
Granted: 2012-04-19
Abstract: This invention includes uses and methods of preparing phosphites and/or hypophosphites (and their polymeric forms and/or their salts) and phosphite-based agrochemicals (fertilizers and biocides) from phosphate or other naturally occurring or synthetic phosphorus sources using anaerobic microbial fermentation. The fermentation process produces both a liquid and solid phase phosphite/hypophosphite salts which can be used as an agrochemical product.
Patent AU-2008228606-B2 (AU)
Title: Hydrocarbon composition useful as a fuel and fuel oil containing a petroleum component and a component of a biological origin
Inventor: PETRI JOHN ANTHONY
IPC: C10L1/08
Filed: 2008-03-05
Granted: 2013-08-15
Abstract: The invention relates to a hydrocarbon composition, which can be used as a fuel and/or fuel oil, containing a petroleum component (A) and a component of a biological origin (B), wherein the component of a biological origin is present in a quantity of up to 75% by volume with respect to the total composition. Said component of a biological origin (B) is prepared starting from a mix of a biological origin (C) containing esters of fatty acids, with possible aliquots of free fatty acids, by means of a process which comprises the following steps: 1) hydrodeoxygenation of the mix of a biological origin; 2) hydroisomerization of the mix resulting from step (1), after possible water and gas flow separation, wherein said hydroisomerization is preferably carried out in the presence of a catalytic system comprising: a) a carrier of an acidic nature, comprising a completely amorphous micro-mesoporous silica-alumina, with a SiO
Patent AU-2008238176-B2 (AU)
Title: Controlling pests by combining insecticides and transgenic plants by applying directly to leaves and roots
Inventor: FUNKE CHRISTIAN
IPC: A01N43/56
Filed: 2008-04-14
Granted: 2014-11-06
Abstract: The invention relates to a method for controlling pests by combining insecticides and transgenic plants and as a result for better utilizing the production potential of transgenic plants. Said plant is treated with a combination of active substances containing an active substance from the group of anthranillic acid amids and at least one other insecticide.
Patent AU-2008253125-B2 (AU)
Title: Oral dosage form providing fast absorption of drug
Inventor: RAULT ISABELLE
IPC: A61K9/48
Filed: 2008-04-24
Granted: 2013-11-07
Abstract: The invention relates to a certain oral dosage form providing absorption of the drug diclofenac in an ultrafast manner.
Patent AU-2008261112-B2 (AU)
Title: Sensor cable and mulitplexed telemetry system for seismic cables having redundant/reversible optical connections
Inventor: MAAS STEVEN J
IPC: G02B6/10
Filed: 2008-12-18
Granted: 2013-08-29
Abstract: Abstract [0056] An optical sensor cable includes at least one light source fiber extending substantially the entire length of the cable. A plurality of optical sensors are functionally coupled at an input thereof to the at least one light source fiber. At least one signal return fiber extends substantially along the entire length of the cable and is functionally coupled to an output of each of the optical sensors. The at least one source light fiber and the at least one signal return fiber are configured to be coupled at either end thereof to a respective one of a light source and a photodetection device. Wi W2 10 JUMPER 22A 22A 22A424 22B 22 B 2 20 22C 40 2C 22D 42%44 TO< PHOTO 32 34 40A --- Wi W2 12 FROM24 Ir24 r16161 FROM e SOURCE 2 22 > 22A 22A 22A 20 228 22B 22B424 22C 40 22C 22D 4 4 TO PHOTO 32 34 40A
Patent AU-2008320815-B2 (AU)
Title: Use of halogenated phthalocyanines
Inventor: PEUMANS PETER
IPC: C07D487/22
Filed: 2008-10-31
Granted: 2014-07-03
Abstract: The present invention relates to the use of halogenated phthalocyanines as charge transport materials and/or as absorber materials.